The ACC/AHA Task Force on Practice Guidelines was formed to make recommendations
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …

Late-breaking clinical trials presented at the 2007 and 2008 annual scientific meetings of the
ACC, AHA, Transcatheter Cardiovascular Therapeutics, the European Society of Cardi-

… Peterson … Eric Peterson, MD, FACC, Associate Professor of Medicine and Director,
Cardiovascular Outcomes, Duke University Medical Center, Durham, NC. … Peterson …

Background Goal-directed therapy has been used for severe sepsis and septic shock in the
intensive care unit. This approach involves adjustments of cardiac preload, afterload, and …

The recommendations listed in this CPG are, whenever possible, evidence based. An extensive
evidence review was conducted through October 2012, and other selected references …

Despite the global impact and advances in understanding the pathophysiology of cerebrovascular
diseases, the term “stroke” is not consistently defined in clinical practice, in clinical …

Background Data are lacking on the long-term effect on cardiovascular events of adding
sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and …

(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies for …

• To ascertain the prevalence of posttraumatic stress disorder (PTSD) and risk factors
associated with it, we studied a random sample of 1007 young adults from a large health …

There is compelling evidence that members of the caspase (interleukin-1β converting
enzyme/CED-3) family of cysteine proteases and the cytotoxic lymphocyte-derived serine protease …